ZA83816B - Anti-viral compositions - Google Patents

Anti-viral compositions

Info

Publication number
ZA83816B
ZA83816B ZA83816A ZA83816A ZA83816B ZA 83816 B ZA83816 B ZA 83816B ZA 83816 A ZA83816 A ZA 83816A ZA 83816 A ZA83816 A ZA 83816A ZA 83816 B ZA83816 B ZA 83816B
Authority
ZA
South Africa
Prior art keywords
salts
hsv
viral compositions
acid
halogenovinyl
Prior art date
Application number
ZA83816A
Other languages
English (en)
Inventor
Kendall O Smith
Original Assignee
Ens Bio Logicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22167810&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA83816(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ens Bio Logicals Inc filed Critical Ens Bio Logicals Inc
Publication of ZA83816B publication Critical patent/ZA83816B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA83816A 1982-02-12 1983-02-07 Anti-viral compositions ZA83816B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1982/000182 WO1983002723A1 (en) 1982-02-12 1982-02-12 Anti-viral compositions

Publications (1)

Publication Number Publication Date
ZA83816B true ZA83816B (en) 1983-12-28

Family

ID=22167810

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA83816A ZA83816B (en) 1982-02-12 1983-02-07 Anti-viral compositions

Country Status (9)

Country Link
EP (1) EP0101441B1 (enExample)
JP (1) JPS59500317A (enExample)
AT (1) ATE24836T1 (enExample)
DE (1) DE3275061D1 (enExample)
HK (1) HK78089A (enExample)
IT (1) IT1212699B (enExample)
MC (1) MC1585A1 (enExample)
WO (1) WO1983002723A1 (enExample)
ZA (1) ZA83816B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
WO1992009285A1 (en) * 1990-11-27 1992-06-11 The Procter & Gamble Company Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
HUT72604A (en) * 1992-12-03 1996-05-28 Merrell Dow Pharma Compositions containing acyclovir-like compounds and 2`-vinyl substituted nucleoside analogs for the treatment of viral infections
WO1996001638A1 (en) * 1994-07-11 1996-01-25 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
CZ284920B6 (cs) * 1996-02-14 1999-04-14 Vladimír Prof. Mudr. Drsc. Vonka Preparáty pro léčbu rekurentního herpesu založené na potenciaci účinků syntetických virostatik kofeinem

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner

Also Published As

Publication number Publication date
DE3275061D1 (en) 1987-02-19
JPS59500317A (ja) 1984-03-01
IT8319583A0 (it) 1983-02-14
EP0101441B1 (en) 1987-01-14
ATE24836T1 (de) 1987-01-15
MC1585A1 (fr) 1985-02-22
HK78089A (en) 1989-10-06
WO1983002723A1 (en) 1983-08-18
EP0101441A1 (en) 1984-02-29
EP0101441A4 (en) 1985-04-11
IT1212699B (it) 1989-11-30
JPH0138770B2 (enExample) 1989-08-16

Similar Documents

Publication Publication Date Title
ATE91233T1 (de) Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.
GB2167283B (en) Improvements in or relating to a method of making an improved food composition.
SE8601709D0 (sv) Farmaceutiskt medel samt komposition innehallande detta
FI971188A7 (fi) Terapeuttinen vitamiini-kalsium yhdistelmä yksikköannoksena galeenisen tabletin muodossa, menetelmä sen valmistamiseksi ja sen käyttö
DE3275061D1 (en) Anti-viral compositions
EP0222608A3 (en) Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as active ingredient
IE872562L (en) Nucleoside for aids treatment.
ZA841241B (en) Dimethylaminomethylenated anti-herpes compounds
GR3021003T3 (en) Antineoplastic effect potentiator and antineoplastic agent
ES543833A0 (es) Procedimiento para combatir la varoatosis en las abejas
FR2534809B1 (fr) Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
CA2207503A1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
FI833504A7 (fi) 9-(1,3-dihydroksi-2- propoksimetyyli)guaniinin 1- monofosfaattiesterit, 1,3-bisfosfaattiestbisfosfaattiesterit ja sykliset fosfaattiesterit antiviraalisina aineiaineina.
DE3065940D1 (en) Synergistic antihypertensive compositions
Smith Anti-viral compositions.
JPS5690015A (en) Preventive and remedy containing human ceruloplasmin as main component
IE821856L (en) 5-(2-halogenovinyl) -2' -deoxyuridine antiviral agents
IT8920927A0 (it) Procedimenti per la preparazione di composti prostanoici ad attivita' antiaggregante piastrinica, antitrombotica, composizioni farmaceutiche che li contengono.